Looking at EkaScribe and wondering what else is out there? Here’s the honest version. EkaScribe is a strong, India-native AI scribe, and it does one thing we don’t yet: live ABDM integration. So we’ll lead with that concession, then show you where AI Medical Scribe by Patient Square is the better pick. No vendor is best at everything. Better you know the real trade-off before a trial than after.
Key takeaways
- EkaScribe has live ABDM integration (M1, M2, M3 certified). We don’t. ABDM is on our roadmap, not shipping. If ABHA linking inside your scribe is non-negotiable today, that’s a real reason to pick eka.care.
- EkaScribe Pro is ₹1,499/month scribe-only; we’re ₹1,799/month ex-GST (about ₹2,123 with 18% GST) on annual billing, scribe plus practice tools in one price. Add an EMR to EkaScribe and the eka stack is ₹2,600–3,000/month, above our bundle.
- Where we pull ahead: a deterministic prescription safety screener, audio that’s never stored, and notes always in clean clinical English from a Hinglish consult.
- Practo Ray and HealthPlix are EMRs with documentation features, not standalone scribes. Frame them that way when you compare.
AI Medical Scribe by Patient Square ex-GST (annual), scribe plus practice tools; EkaScribe Pro is ₹1,499/mo scribe-only
ABDM milestones eka.care has live; ours is roadmap, not shipping
audio recordings we retain: processed in memory, discarded at note draft
What does EkaScribe do well, honestly?
Credit where it’s earned. That’s the whole point of an honest comparison.
EkaScribe is built by eka.care, an India-native health platform. It was positioned as India’s first AI medical scribe, runs on the company’s own language model, and handles 20-plus Indian languages. Its published price is ₹1,499 per doctor per month for the scribe alone, with an annual plan near ₹12,492 a year and a free tier that allows five consultations a day. The EMR is a separate eka plan, so a clinic that needs both is buying two products. Still, that’s a clear, India-denominated rate card, which already puts it ahead of the global vendors who quote you in dollars or route you to a sales call.
The biggest single thing EkaScribe has that we don’t is live ABDM integration. eka.care has M1, M2, and M3 milestones certified by the National Health Authority, an ABDM Connect API, and a health locker for ABHA-linked records. If your clinic’s workflow depends on creating or linking ABHA IDs and pushing records into the national health stack today, EkaScribe does that now. AI Medical Scribe by Patient Square does not. ABDM integration is on our roadmap. We’re not going to pretend otherwise, and any comparison that buries this is lying to you.
So if you’ve read this far and ABDM-today is the deciding factor, you can stop here and choose eka.care with our blessing. For everyone else, here’s where we’re the stronger pick.
EkaScribe vs the alternatives: the India scribe table
| EkaScribe (eka.care) | AI Medical Scribe by Patient Square | Augnito | Practo Ray / HealthPlix | |
|---|---|---|---|---|
| Product type | Ambient scribe inside a health platform | Focused ambient scribe | Dictation + voice commands (Spectra); ambient (Omni) | EMR with documentation features |
| Published India price | ₹1,499/mo (Pro, scribe-only); ~₹12,492/yr annual; EMR sold separately | ₹1,799/mo ex-GST annual (~₹2,123 with GST), scribe + practice tools | Sales-led, no transparent self-serve ₹ rate | EMR subscription, not a scribe price |
| Live ABDM integration | Yes (M1–M3 certified) | Roadmap, not shipping | Not the product focus | Varies by platform |
| Prescription handling | Voice-to-prescription | Rx draft + deterministic safety screener | Dictation-led | EMR Rx module |
| Visit audio | Per their policy | Processed in memory, never stored | Per their policy | Per their policy |
| Note output language | English / structured | Clean clinical English | English | English |
| Free trial | Free tier: 5 consults/day | 7-day full trial, no daily cap | 7-day trial | Demo-led |
A note on that last column. Practo Ray and HealthPlix come up constantly when doctors search for scribe alternatives, but they’re EMR products with documentation features bolted on, not standalone ambient scribes. If you want a full practice-management EMR, look at them. If you want a tool that listens during the visit and hands back a note, they’re not really in this comparison, and lumping them in would mislead you.
Where is AI Medical Scribe by Patient Square the better pick?
Three places, and they’re concrete.
Start with prescription safety. AI Medical Scribe by Patient Square is an ambient AI medical scribe that builds a live transcript as you speak and hands back a structured SOAP note, ICD-10 suggestions, and a prescription draft the moment the visit ends, ready to review and sign. The prescription draft passes through a deterministic safety screener that checks drug interactions, renal dosing, and pregnancy flags, re-runs at sign time, and hard-blocks unsafe combinations unless you override with an attestation. A draft an LLM wrote is still a draft an LLM wrote. We wanted that safety layer deterministic, not probabilistic, because that’s the part where a wrong guess hurts a patient.
Then there’s the audio, or rather the lack of it. Visit audio is processed in memory and discarded the moment the note is drafted. No audio archive, for us or for the practice. Under the DPDP Act 2023, the less sensitive data you retain, the smaller your exposure, and a recording is more revealing than the note. The full posture is on our security page.
And the pricing is honest, with no daily cap. We’re ₹1,799 per clinician per month ex-GST on annual billing, about ₹2,123 once you add 18% GST, and that one price carries the scribe plus practice tools rather than billing the EMR separately. There’s a 7-day free trial, the real product, no five-consultations-a-day ceiling while you evaluate. The complete ladder, with the with-GST math, is on the India rate card and the pricing page.
If those three things matter more to you than ABDM-today, and you’d rather buy scribe and practice tools as one bundle than stitch two products together, we’re the switch worth trialing. If you only want a standalone scribe and already run an EMR, EkaScribe’s lower scribe-only price is the honest call.
How do you actually choose between them?
Run both. Seriously. This is a clinical tool, and a feature list can’t tell you whether the note from your Tuesday OPD is signable.
Pick a real clinic morning. Use EkaScribe’s free tier for part of it and our 7-day trial for the rest, on the same kinds of patients, your accents, your Hinglish, your interruptions. Then read the notes side by side and ask three questions: Is the SOAP note clean enough to sign without a rewrite? Did the prescription draft catch anything risky? Where did the visit audio go, and can each vendor tell you in one sentence? The India scribe market is small enough that a parallel run takes a week, and the answer you get is worth more than any table, including this one.
When you’re ready to see ours on your own consults, book a demo and we’ll walk through it on the kind of cases you actually see. If you’d rather start with numbers, the India comparison lines us up against EkaScribe and Augnito, and the Hindi and Hinglish post shows a real code-mixed consult turning into an English note.
When is EkaScribe the better fit?
Plainly: when live ABDM integration is a today requirement, not a someday one. If your clinic is building around ABHA linking, the national health stack, or AB-PMJAY workflows that depend on ABDM connectivity, eka.care has shipped that and we haven’t. That’s the cleanest reason to choose EkaScribe over us, and it’s an honest one. It’s also a roadmap item for us, so this gap is one we intend to close, but you should buy what ships, not what’s promised.
For prescription safety, audio that’s never stored, transparent uncapped pricing at ₹1,799 for scribe plus practice tools, and a clean English note from a Hinglish visit, we think we’re the better daily driver. The only way to know for your clinic is to run both for a week. Book a demo and put us on a real OPD morning.